tradingkey.logo
tradingkey.logo

Enhabit Inc

EHAB
13.660USD
-0.010-0.07%
Close 03/26, 16:00ETQuotes delayed by 15 min
681.61MMarket Cap
LossP/E TTM

Enhabit Inc

13.660
-0.010-0.07%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Enhabit Inc

Currency: USD Updated: 2026-03-26

Key Insights

Enhabit Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 46 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 13.83.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Enhabit Inc's Score

Industry at a Glance

Industry Ranking
46 / 75
Overall Ranking
216 / 4546
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Enhabit Inc Highlights

StrengthsRisks
Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.
Undervalued
The company’s latest PE is -150.86, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.65M shares, decreasing 0.04% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 365.80K shares of this stock.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
13.833
Target Price
+1.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-26

The current financial score of Enhabit Inc is 6.48, ranking 54 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 270.40M, representing a year-over-year increase of 4.73%, while its net profit experienced a year-over-year increase of 15.87%.

Score

Industry at a Glance

Previous score
6.48
Change
0

Financials

5.76

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.26

Operational Efficiency

6.93

Growth Potential

6.35

Shareholder Returns

7.12

Enhabit Inc's Company Valuation

Currency: USD Updated: 2026-03-26

The current valuation score of Enhabit Inc is 8.80, ranking 3 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -150.86, which is -98.58% below the recent high of -2.14 and -0.07% above the recent low of -150.97.

Score

Industry at a Glance

Previous score
8.80
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 46/75
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-26

The current earnings forecast score of Enhabit Inc is 6.33, ranking 57 out of 75 in the Healthcare Providers & Services industry. The average price target is 9.25, with a high of 11.00 and a low of 8.50.

Score

Industry at a Glance

Previous score
6.00
Change
0.33

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
13.833
Target Price
+1.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
7
Median
9
Average
Company name
Ratings
Analysts
Enhabit Inc
EHAB
6
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-26

The current price momentum score of Enhabit Inc is 3.83, ranking 71 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 13.71 and the support level at 13.60, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
3.82
Change
0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
-0.211
Neutral
RSI(14)
78.362
Buy
STOCH(KDJ)(9,3,3)
72.872
Neutral
ATR(14)
0.035
Low Volatility
CCI(14)
158.827
Buy
Williams %R
30.000
Buy
TRIX(12,20)
0.488
Sell
StochRSI(14)
17.941
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
13.646
Buy
MA10
13.630
Buy
MA20
13.620
Buy
MA50
12.198
Buy
MA100
10.621
Buy
MA200
9.300
Buy

Institutional Confidence

Currency: USD Updated: 2026-03-26

The current institutional shareholding score of Enhabit Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 122.69%, representing a quarter-over-quarter decrease of 1.36%. The largest institutional shareholder is The Vanguard, holding a total of 3.30M shares, representing 6.51% of shares outstanding, with 11.32% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
8 knots Management LLC
4.22M
+9.49%
Deerfield Management Company, L.P.
4.75M
-0.67%
BlackRock Institutional Trust Company, N.A.
3.43M
+2.53%
The Vanguard Group, Inc.
Star Investors
3.32M
+6.56%
AREX Capital Management, LP
2.49M
+0.26%
JANA Partners LLC
Star Investors
2.14M
--
UBS Financial Services, Inc.
3.13M
-6.30%
Systematic Financial Management, L.P.
1.94M
-0.17%
Dimensional Fund Advisors, L.P.
1.98M
-2.93%
Paradice Investment Management LLC
1.74M
--
1
2

Risk Assessment

Currency: USD Updated: 2026-03-26

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Enhabit Inc is 6.10, ranking 32 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
6.10
Change
0
Beta vs S&P 500 index
1.12
VaR
--
240-Day Maximum Drawdown
+39.63%
240-Day Volatility
+45.45%

Return

Best Daily Return
60 days
+22.63%
120 days
+22.63%
5 years
--
Worst Daily Return
60 days
-3.40%
120 days
-6.09%
5 years
--
Sharpe Ratio
60 days
+3.14
120 days
+2.56
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+39.63%
3 years
+54.82%
5 years
--
Return-to-Drawdown Ratio
240 days
+1.83
3 years
+0.04
5 years
--
Skewness
240 days
+1.91
3 years
+0.30
5 years
--

Volatility

Realised Volatility
240 days
+45.45%
5 years
--
Standardised True Range
240 days
+2.19%
5 years
--
Downside Risk-Adjusted Return
120 days
+574.78%
240 days
+574.78%
Maximum Daily Upside Volatility
60 days
+56.53%
Maximum Daily Downside Volatility
60 days
+53.59%

Liquidity

Average Turnover Rate
60 days
+1.27%
120 days
+1.00%
5 years
--
Turnover Deviation
20 days
-0.53%
60 days
+19.29%
120 days
-5.96%

Peer Comparison

Healthcare Providers & Services
Enhabit Inc
Enhabit Inc
EHAB
6.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
MD
8.16 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
Natera Inc
NTRA
8.14 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.11 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
Ensign Group Inc
ENSG
8.09 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI